Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Quaternary-salts-as-hypoglycemic-agents

 Heterocyclic compounds, processes for their preparation and their use
We claim: 1. A compound of general formula (I): ##STR14## in which the amide function is in the 2 ...


 Virus insecticide compositions
What is claimed is: 1. A particulate insecticidal composition comprising a free-flowing particle ...


 Stable prostaglandin E group-containing formulation
OF THE INVENTION Now, as described above, thiol compounds, water-soluble high molecular weight ...


 Medicinal facial mask
OF THE INVENTION The compositions of the present invention comprise a pharmaceutically and ...


 p75 TNF receptor promoters
OF THE INVENTION A human genomic library containing the human p75 TNF-R was obtained from S...


 Method of immunizing cats against shedding of Toxoplasma oocysts
I claim: 1. A method of immunizing a cat against shedding of Toxoplasma oocysts which comprises the ...


 Vaccine for immunizing cats against toxoplasma oocyst shedding
What is claimed is: 1. A method of immunizing cats against Toxoplasmosis without concomitant oocyst ...


 Attenuated viruses
We claim: 1. An attenuated poliovirus in which there is a reversal of a base pairing in the part, ...


 Chimeric nucleic acids and proteins for inhibiting HIV-1 expression
OF THE INVENTION A fusion protein according to the invention includes NS1 and Rev proteins or ...


 Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
OF THE INVENTION The method of the present invention for inhibiting the activity of HMG-CoA in ...


 Quaternary salts as hypoglycemic agents

Details
Inventors: Kuhla, Donald E.;
Assignee: Pfizer Inc. (New York, NY)
Primary Examiner: Randolph; John D.
Assistant Examiner:
Attorney, Agent or Firm: Connolly and Hutz

The synthesis of imidazo[1,2-a]pyridinium, imidazo[1,5-a]pyridinium, pyrrolo[1,2-a]pyrazinium, pyrazolo[1,5-a]pyridinium, imidazo[2,1-a]isoquinolinium and imidazo[5,1-a]isoquinolinium quaternary salts and their use as hypoglycemic agents.

DETAILED DESCRIPTION OF THE INVENTION The hypoglycemic agents of the present invention are synthesized by the reaction of a suitable halide with the appropriate heterocyclic ring system, depicted as follows: ##STR6## wherein R, R.
sub.
2, R.
sub.
1, R.
sub.
3, R.
sub.
4, R.
sub.
5, R.
sub.
6, Q, Y, Z and X are as previously described.
Transformation of the above-mentioned heterocyclic compounds to quaternary salts is effected by reacting with a halide where X is preferably chloro, bromo or iodo.
Said reaction can be conducted between equimolar amounts of the two reagents either neat or in the presence of a suitable reaction-inert solvent.
When conducted neat a large excess of the halide can be employed, acting under these conditions as both a reactant and solvent.
By a reaction-inert solvent is meant one which does not react to any appreciable degree with the product or reactants under the conditions of said reaction.
Solvents suitable for the solublizing of the reactants leading to the quaternary compounds can be of a varied nature, and can include (lower)alkanols, (lower)alkylnitriles, di(lower)alkyl ketones, cyclic- and di(lower)alkyl ethers and liquid aromatic hydrocarbons.
The preferred solvent for this reaction is acetonitrile.
Reaction time is not critical, and depends on temperature, concentration and inherent reactivity of the reagents.
When steam bath temperatures are employed, completion of the reaction usually requires overnight heating.
The product is isolated by cooling the reaction mixture to induce crystallization, or initial concentration of the reaction mixture followed by cooling and addition of a second solvent to induce crystallization.
Further purification of the final product is facilitated by trituration or recrystallization from an appropriate solvent.
As mentioned previously, quaternary salt formation is preferably effected wherein X of the alkylating agent is bromo, chloro, or iodo.
Following isolation of these salts the nature of the X variable can be altered by initially treating an aqueous solution of quaternary halide with an equivalent of silver oxide, followed by separation of the precipitated silver halide and treatment of the aqueous solution of the quaternary base with at least an equivalent of an appropriate acid HX



Related patents
  7-[.alpha.-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
We claim: 1. An acid having the formula ##SPC42## wherein R is ##SPC43## ##SPC44## or ##EQU1## or a nontoxic, pharmaceutically acceptable salt thereof. 2. The acid of ...
  Pasteurized therapeutically active protein compositions
What is claimed is: 1. A method of pasteurizing a composition comprising a thermally sensitive, therapeutically active protein selected from the group consisiting of ...
  Method of preparing a high-purity, virus safe, biologically active transferrin preparation
We claim: 1. A method of preparing a high-purity, virus-safe biologically active, transferrin preparation from plasma fractions that contain transferrin, comprising a) ...
  Hydrolyzable resin composition and an antifouling coating composition containing the same
What is claimed is: 1. A method of preventing marine fouling which comprises applying to a surface to be protected from fouling, an anti-fouling hydrolyzable resin ...
  Treatment for herpes virus
OF THE INVENTION According to the invention, I provide a composition for and method of use of such composition, for the topic treatment of herpes virus lesions, which ...
  Microbicidal meta oxy- and thio-substituted phenylanilines
What is claimed is: 1. A compound of the formula I, including salts and metal complexes thereof ##STR52## wherein R.sub.1 and R.sub.2 independently of one another are ...
  Synergistic microbiocidal composition containing a mixture of a bicyclic polyoxymethyleneoxazolidine and an acroloin/formaldehyde polycondensation product
We claim: 1. A microbiocidal composition comprising a synergistic mixture the first component of which is an acrolein/formaldehyde polycondensation product having a ...
  Substituted acyl derivatives of amino acids
OF THE INVENTION The invention in its broad aspects includes substituted acyl derivatives of amino acids having formula I above. The substituted acyl groups refer to ...
  Escherichia coliO-polysaccharide-protein conjugate vaccine
OF THE INVENTION The present invention relates to E. coli-protein conjugates for use in vaccines against E. coli. The present invention further relates to a method of ...
  Milk production
What is claimed is: 1. The method of improving rumen acetate/propionate ratios and milk production which is well known to be closely related to a high acetate/propionate ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved